Welcome to our dedicated page for Coupang SEC filings (Ticker: CPNG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Coupang, Inc. filings document the regulatory record for a NYSE-listed technology and commerce company with Product Commerce and Developing Offerings segments. Form 8-K reports include quarterly and annual operating results, segment revenue, gross profit, adjusted EBITDA, cash-flow measures and Class A common stock repurchases.
Proxy materials describe annual meeting proposals, director elections, auditor ratification and advisory executive-compensation votes. Other filings record cybersecurity incident disclosures involving Coupang Corp., governance and leadership changes, regulatory cooperation, potential penalties and related risk disclosures.
Coupang, Inc. institutional investors SVF Investments (UK) Limited and SB Investment Advisers (UK) Limited report shared beneficial ownership of 309,542,259 Class A shares, equal to 18.7% of the outstanding Class A stock based on 1,657,810,034 shares disclosed in the issuer's quarterly report. SVF Investments (UK) Limited is the record holder of the reported shares and SBIA UK has been appointed as its alternative investment fund manager and is exclusively responsible for making investment decisions for SVF Investments.
The reporting persons state shared voting power and shared dispositive power over the 309,542,259 shares and report no sole voting or sole dispositive power. A joint filing agreement is referenced as Exhibit 99.
Coupang's Chief Financial Officer, Gaurav Anand, reported the sale of 75,350 shares of Class A common stock on 08/11/2025 at a weighted average price of $27.7877 per share under a Rule 10b5-1 trading plan adopted on December 8, 2024 to satisfy tax obligations. The filing states the shares were sold in multiple transactions at prices ranging from $27.65 to $28.02. After the reported sale, Mr. Anand beneficially owns 2,016,940 shares directly; an additional 150,000 shares are held of record by the Gaurav Anand 2021 Trust, for which his spouse serves as trustee. The report was signed by an attorney-in-fact.
Coupang insider Gaurav Anand submitted a Form 144 to notify a proposed sale of 75,350 common shares, with an aggregate market value of $2,096,990.50, to be executed on or about 08/11/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The filing shows those shares were acquired by previously exercised stock options on 10/21/2020 (12,100 shares) and 12/13/2021 (63,250 shares), with payment in cash. The notice also reports recent May 2025 sales by the same person: 175,000 shares for $4,919,635.00 and 75,350 shares under a 10b5-1 plan for $1,966,921.33. The proposed sale represents approximately 0.0045% of the 1,665,262,233 shares outstanding reported in the filing, and the filer affirms no undisclosed material adverse information.